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What information do patients need about medicines?
David Dickinson, D K Theo Raynor; James G Kennedy; Silvia Bonaccorso, Jeffrey L Sturchio
Partnership between health professionals and patients depends, in part, on the provision and
exchange of accurate and reliable information about drugs, but who should provide it?
We invited contributors to answer the question from the perspectives of patients, clinicians,
and the pharmaceutical industry
Ask the patients—they may want to know more than you think
David Dickinson, D K Theo Raynor
People’s appetite for information about their treat-
ment is often greater than doctors believe.1 Clearly,
patients vary in the extent of their desire for partner-
ship in making medical decisions. It follows that part
of the duty of a health professional is to work out how
much partnership a patient wants, and what
information he or she needs to support that level of
partnership.2 3
What do people want to know?
People have a broad range of information preferences
that may differ at different times and for different
reasons. They may want more information than
prescribers want to give—for example, about the possi-
ble side effects of a drug.1 4 They may place different
interpretations on information about likely risks, and
they may question the benefits of taking a drug when
they are not greatly concerned by the medical
“problem” that the treatment is meant to solve. They
may well rate the practicalities of how to take a drug
higher than the details of the inert components of the
pills or the drug manufacturer’s address.
In interviewing people about drug treatments,5 6 we
have consistently noticed that people respond to four
essential aspects of a drug:
x Side effects
x What it does and what it’s for
x Do’s and don’ts
x How to take it.
Who is trusted as a source of
information?
Our work with medicine users shows clear trends, in
common with consumer surveys:
x Health professionals are the most popular source
for drug advice
x Electronic media (internet and television) are
becoming important sources
x Non-expert help (such as friends and family) is
always popular.
A range of information sources is preferred, but
that doesn’t challenge health professionals’ premier
position. Lay or non-expert sources are generally used
to help people fit expert information into their every-
day life or to fill the gaps after a consultation that left
certain questions unanswered.
It follows that the ideal source of drug information
would be
x Accurate, up to date, reliable, and practically useful
x Accessible in language, format, and tone
x Capable of customisation or personalisation
x Available at different levels of detail at different
times
x Informative about conditions as well as treatments
x Striking a balance between a treatment’s beneficial
and adverse effects
x Available at the time of a consultation and
consistent with best advice
x Linked to other reliable and consistent sources of
advice and information.
A structured source of information to enable better
use of drugs in Britain is being piloted as part of “Ask
about medicines week.” Under the guidance of an advi-
sory board that includes representatives of patients,
health professionals, regulatory authorities, and the
drug industry, new sources of information have been
drafted. Medicine guides—practical online guides to
individual drugs—are linked to new content on NHS
Direct Online about the conditions being treated. The
pilot project covers epilepsy and colds and flu. The aim
of the project is to provide access to consistent, high
quality,multilevel patient information that complements
the detailed information leaflets contained in most drug
packs. This information should eventually be accessible
in multiple media and could be used by doctors, nurses,
and pharmacists for personalised counselling whenever
drugs are prescribed or dispensed.
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